← Back
$KNSA All transactions

Kiniksa Pharmaceuticals International, plc

M 10b5-1 Plan

$ Value

Shares

2,477

Price

Filed

Apr 8

Insider

Name

Moat Ross

Title

CHIEF OPERATING OFFICER

CIK

0001857177

Roles

Officer

Transaction Details

Transaction Date

2026-04-07

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

14,506

Footnotes

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on November 13, 2024. | Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. | The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022.

Filing Info

Accession No.

0001857177-26-000004

Form Type

4

Issuer CIK

0001730430

Moat Ross's History

Date Ticker Type Value
2026-04-09 KNSA $80K
2026-04-07 KNSA M
2026-04-07 KNSA F $38K
2026-04-07 KNSA M $0
2026-04-06 KNSA $115K
2026-04-01 KNSA M
2026-04-01 KNSA F $82K
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0

Other Insiders at KNSA (90d)

Insider Bought Sold Last
Quart Barry D $345K 2026-04-06
Megna Michael R
CHIEF ACCOUNTING OFFICER
$309K 2026-04-09
Patel Sanj K
CHAIRMAN & CEO
$364K 2026-04-07
Paolini John F.
CHIEF MEDICAL OFFICER
2026-04-07
Ragosa Mark
CHIEF FINANCIAL OFFICER
2026-04-07
Moat Ross
CHIEF OPERATING OFFICER
$195K 2026-04-09
Tessari Eben
CHIEF STRATEGY OFFICER
2026-04-07